BeStock  
Markets › Compare › LKFT vs ZLAB

LKFT vs ZLAB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LKFT · Lakefront Biotherapeutics$33.31 ▼ 0.24%
ZLAB · Zai Lab$21.03 ▼ 4.06%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

7994109124139Nov 24, '25May 26, '26Nov 20, '26
  • LKFT +7.3%
  • ZLAB +5.5%

Head to head

MetricLKFTZLAB
Price$33.31$21.03
Change today▼ 0.24%▼ 4.06%
Market cap$2.18B$2.36B
Return, 3 months+14.7%-18.0%
Return, year to date+1.9%+19.2%
Return, 1 year+8.6%+5.0%
P/E (TTM)2.5–
P/B0.64.2
P/E percentile vs own 5y61st15th
Dividend yield––
Revenue growth (YoY, latest qtr)-89.4%-6.8%
Net profit growth (YoY)+98.7%-28.3%
Gross margin98.1%54.7%
Operating margin65.8%-61.7%
Net margin85.9%-44.9%
Return on equity28.0%-30.0%
Analyst target vs. price+35.1%+87.0%
Analyst buy share100%100%
RSI (14)5737
30-day volatility25.7%72.3%
Max drawdown, 1 year-24.7%-34.7%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ZLAB is the largest of the group by market value.
  • LKFT has returned the most over the past year.
  • ZLAB is growing revenue fastest.
  • LKFT keeps the most profit per dollar of sales.
  • LKFT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top